6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
NCT00738738
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Please see Detailed Description for termination reason.
Conditions
Generalized Anxiety Disorder
Interventions
DRUG:
PD-0332334
Sponsor
Pfizer